Chronic glutamate toxicity in neurodegenerative diseases—what is the evidence?

J Lewerenz, P Maher - Frontiers in neuroscience, 2015 - frontiersin.org
Together with aspartate, glutamate is the major excitatory neurotransmitter in the brain.
Glutamate binds and activates both ligand-gated ion channels (ionotropic glutamate …

Huntington's disease: mechanisms of pathogenesis and therapeutic strategies

M Jimenez-Sanchez, F Licitra… - Cold Spring …, 2017 - perspectivesinmedicine.cshlp.org
Huntington's disease is a late-onset neurodegenerative disease caused by a CAG
trinucleotide repeat in the gene encoding the huntingtin protein. Despite its well-defined …

Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan

R Castro-Portuguez, GL Sutphin - Experimental gerontology, 2020 - Elsevier
Aging is characterized by a progressive decline in the normal physiological functions of an
organism, ultimately leading to mortality. Nicotinamide adenine dinucleotide (NAD+) is an …

Kynurenines in the mammalian brain: when physiology meets pathology

R Schwarcz, JP Bruno, PJ Muchowski… - Nature Reviews …, 2012 - nature.com
The essential amino acid tryptophan is not only a precursor of serotonin but is also
degraded to several other neuroactive compounds, including kynurenic acid, 3 …

Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases

MD Lovelace, B Varney, G Sundaram, MJ Lennon… - …, 2017 - Elsevier
The kynurenine pathway (KP) of tryptophan metabolism has emerged in recent years as a
key regulator of the production of both neuroprotective (eg kynurenic and picolinic acid, and …

Role of kynurenine pathway in oxidative stress during neurodegenerative disorders

A Mor, A Tankiewicz-Kwedlo, A Krupa, D Pawlak - Cells, 2021 - mdpi.com
Neurodegenerative disorders are chronic and life-threatening conditions negatively affecting
the quality of patients' lives. They often have a genetic background, but oxidative stress and …

Kynurenines in the CNS: recent advances and new questions

L Vécsei, L Szalárdy, F Fülöp, J Toldi - Nature reviews Drug discovery, 2013 - nature.com
Various pathologies of the central nervous system (CNS) are accompanied by alterations in
tryptophan metabolism. The main metabolic route of tryptophan degradation is the …

Molecular mechanisms and potential therapeutical targets in Huntington's disease

C Zuccato, M Valenza, E Cattaneo - Physiological reviews, 2010 - journals.physiology.org
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat
expansion in the gene encoding for huntingtin protein. A lot has been learned about this …

Kynurenines in CNS disease: regulation by inflammatory cytokines

BM Campbell, E Charych, AW Lee… - Frontiers in neuroscience, 2014 - frontiersin.org
The kynurenine pathway (KP) metabolizes the essential amino acid tryptophan and
generates a number of neuroactive metabolites collectively called the kynurenines …

Quinolinic acid: an endogenous neurotoxin with multiple targets

R Lugo-Huitrón, P Ugalde Muñiz… - Oxidative medicine …, 2013 - Wiley Online Library
Quinolinic acid (QUIN), a neuroactive metabolite of the kynurenine pathway, is normally
presented in nanomolar concentrations in human brain and cerebrospinal fluid (CSF) and is …